Greenwich LifeSciences, Inc. (GLSI)
Nasdaq: GLSI · Pharmaceutical Preparations · Stafford, TX · filing with the SEC since 2020
Who runs Greenwich LifeSciences, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Patel Snehal
CEO and CFO. First filing Sep 2020, latest Jul 30, 2026, 83 filings in all.
Officers reporting now
1
of 1 people with a filing in the last fifteen months
Directors reporting now
0
6 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Patel Snehal | CEO and CFO | Sep 2020 | Jul 30, 2026 | none |
Earlier names on the record7, newest filing first
Daugherty Frank Joseph · officer · last filing Dec 2024Thompson Jaye · officer · last filing Dec 2024Hallock Kenneth · director · last filing Dec 2024Mcwilliams David · director · last filing Dec 2024Rothe Eric · director · last filing Dec 2024Patel Pankaj Amrit · 10% owner · last filing Nov 2020Patel Kinnary · 10% owner · last filing Oct 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.